skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts - A comparative study

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1]; ;  [2];  [3];  [4];  [1]
  1. Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80177, 3508 TD Utrecht (Netherlands)
  2. Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Bangkok (Thailand)
  3. St. Antonius Hospital, PO 2500, 3430 EM Nieuwegein (Netherlands)
  4. Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment, PO Box 1, 3720 BA Bilthoven (Netherlands)

Interference of exogenous chemicals with the aromatase enzyme can be useful as a tool to identify chemicals that could act either chemopreventive for hormone-dependent cancer or adverse endocrine disruptive. Aromatase is the key enzyme in the biosynthesis of steroids, as it converts androgens to estrogens. Certain flavonoids, plant derived chemicals, are known catalytic aromatase inhibitors. Various systems are in use to test aromatase inhibitory properties of compounds. Commonly used are microsomes derived from ovary or placental tissue characterized by high aromatase activity. To a lesser extent whole cell systems are used and specifically cell systems that are potential target tissue in breast cancer development. In this study aromatase inhibitory properties of fadrozole, 8-prenylnaringenin and a synthetic lactone (TM-7) were determined in human placental microsomes and in human primary breast fibroblasts. In addition, apigenin, chrysin, naringenin and two synthetic lactones (TM-8 and TM-9) were tested in human microsomes only. Comparison of the aromatase inhibitory potencies of these compounds between the two test systems showed that the measurement of aromatase inhibition in human placental microsomes is a good predictor of aromatase inhibition in human breast fibroblasts.

OSTI ID:
21140821
Journal Information:
Toxicology and Applied Pharmacology, Vol. 228, Issue 3; Other Information: DOI: 10.1016/j.taap.2007.12.007; PII: S0041-008X(07)00559-5; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English